You are here

  • Home
  • Archive
  • Volume 17, Issue 2
  • In patients hospitalised with acute heart failure, nesiritide, compared with placebo, is not associated with improvements in dyspnoea or 30-day rehospitalisation or mortality

Alerts

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
In patients hospitalised with acute heart failure, nesiritide, compared with placebo, is not associated with improvements in dyspnoea or 30-day rehospitalisation or mortality
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address